Coherus Biosciences Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.7M | 572 | 75.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $925,775 | 300 | 9.1% |
| Consulting Fee | $805,950 | 237 | 7.9% |
| Food and Beverage | $354,876 | 11,973 | 3.5% |
| Honoraria | $239,468 | 125 | 2.3% |
| Travel and Lodging | $150,859 | 587 | 1.5% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CHS170107 | $1.7M | 0 | 16 |
| CHS14209 | $1.6M | 0 | 4 |
| CHS-131-016 | $1.0M | 0 | 1 |
| SRF114-101 | $787,395 | 0 | 57 |
| A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma | $643,935 | 0 | 188 |
| CHS601 | $533,299 | 0 | 81 |
| A Phase 1/1b Study of CHS-388 (formerly known as SRF388) in Patients with Advanced Solid Tumors | $363,371 | 0 | 206 |
| 305 | $312,095 | 0 | 1 |
| CHS-1701-08 | $286,500 | 0 | 4 |
| CHS-131 | $220,086 | 0 | 1 |
| An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (POEM) | $207,775 | 0 | 1 |
| CHS-1701-09 | $59,249 | 0 | 12 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Martin Dietrich, M.d., Ph.d, M.D., PH.D | Student in an Organized Health Care Education/Training Program | Rockledge, FL | $18,474 | $0 |
| Dr. Lori Wirth, Md, MD | Medical Oncology | Boston, MA | $17,486 | $0 |
| Michael Klufas, M.d, M.D | Ophthalmology | Plymouth Meeting, PA | $17,342 | $0 |
| Kristi Orbaugh, Np, NP | Nurse Practitioner | Indianapolis, IN | $16,471 | $0 |
| Baruch Kuppermann, Md, MD | Ophthalmology | Irvine, CA | $16,058 | $0 |
| Dr. Daneng Li, M.d, M.D | Internal Medicine | Duarte, CA | $15,784 | $0 |
| Firas Rahhal, Md, MD | Ophthalmology | Los Angeles, CA | $15,723 | $0 |
| Dr. Kashyap Patel, M.d, M.D | Hematology & Oncology | Rock Hill, SC | $15,652 | $0 |
| Dr. Tanguy Seiwert, M.d, M.D | Medical Oncology | Baltimore, MD | $15,309 | $0 |
| Dr. Gary Kay, M.d, M.D | Hematology & Oncology | Elk Grove Village, IL | $15,238 | $0 |
| Dr. Samir Khleif, M.d, M.D | Specialist | Augusta, GA | $15,000 | $0 |
| Peter Kaiser, Md, MD | Ophthalmology | Cleveland, OH | $14,850 | $0 |
| Robert Avery, M.d, M.D | Retina Specialist | Santa Barbara, CA | $14,436 | $0 |
| Dr. Douglas Adkins, Md, MD | Medical Oncology | Saint Louis, MO | $14,308 | $0 |
| Dr. John Huang, M.d, M.D | Ophthalmology | Hartford, CT | $14,185 | $0 |
| Dr. David Shepard, M.d, M.D | Specialist | Decatur, GA | $14,050 | $0 |
| Mr. Todd Schneiderman, Md, MD | Retina Specialist | Silverdale, WA | $13,797 | $0 |
| Marjorie Hein, Fnp, FNP | Primary Care | Duarte, CA | $13,453 | $0 |
| Robert Rifkin, Md, MD | Hematology & Oncology | Denver, CO | $12,895 | $0 |
| Lee Schwartzberg, Md, MD | Hematology | Reno, NV | $12,286 | $0 |
| Dr. Denise Davis, M.d, M.D | Internal Medicine | Berkeley, CA | $12,000 | $0 |
| Robert Haddad, Md, MD | Internal Medicine | Naples, FL | $11,138 | $0 |
| Dr. Matthew Donovan, Md, MD | Retina Specialist | Clearwater, FL | $10,238 | $0 |
| Hyunseok Kang, Md, MD | Internal Medicine | Stanford, CA | $9,857 | $0 |
| Vincent Chung, Md, MD | Internal Medicine | Duarte, CA | $9,796 | $0 |
About Coherus Biosciences Inc.
Coherus Biosciences Inc. has made $10.2M in payments to 5,259 healthcare providers, recorded across 13,794 transactions in the CMS Open Payments database. In 2024, the company paid $2.2M. The top product by payment volume is Udenyca ($2.7M).
Payments were distributed across 111 medical specialties. The top specialty by payment amount is Ophthalmology ($461,034 to 691 doctors).
Payment categories include: Food & Beverage ($354,876), Consulting ($805,950), Research ($7.7M), Travel & Lodging ($150,859).
Coherus Biosciences Inc. is associated with 3 products in the CMS Open Payments database.